Trump China Tariffs Now At Least 145% As Trade War Ramps Up
President Donald Trump's tariffs on Chinese imports are now at least 145%, far above the level many economists said could decimate US-China trade.
Trump is imposing a 125% charge designed to both counter America's trade deficit with China and punish Beijing for retaliating against US import taxes. The number, published in a White House memo Thursday, comes in addition to a 20% levy put into place earlier this year over China's role in fentanyl trafficking.
The staggering US tariffs on the world's second largest economy have triggered a tit-for-tat trade war that has unnerved global financial markets.
Trump's tariff rollout has been marked by confusion, as Trump has repeatedly shifted course. The president on Wednesday put off plans to impose higher levies on dozens of nations hours after they went into place, even as he escalated his trade fight with Beijing.
The US's other trading partners will face a 10% blanket import tax to allow for a 90-day period to negotiate individual trade agreements. If that doesn't succeed, the higher duties are set to go into place on July 9.
The president's order published Thursday raised taxes even further on small packages from China that were previously not taxed, which could hit American shoppers purchasing goods from retailers like Temu and SheIn Group Ltd.
The US will tax imports of items priced up to $800 at a rate of 120% of their value, up from a prior plan to levy a 90% ad valorem tax.
The per postal item fee on goods entering after May 2 and before June 1 will rise to $100 from the planned $75. Parcels entering after June 1 will face a charge of $200 per item instead of $150 announced previously.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.